Perspective Therapeutics ... (CATX)
AMEX: CATX
· Real-Time Price · USD
5.00
0.16 (3.31%)
At close: Oct 15, 2025, 3:59 PM
4.99
-0.20%
After-hours: Oct 15, 2025, 04:22 PM EDT
3.31% (1D)
| Bid | 4.84 |
| Market Cap | 371.28M |
| Revenue (ttm) | 576K |
| Net Income (ttm) | -113.64M |
| EPS (ttm) | -1.37 |
| PE Ratio (ttm) | -3.65 |
| Forward PE | -3.65 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 5.16 |
| Volume | 1,005,724 |
| Avg. Volume (20D) | 841,720 |
| Open | 4.90 |
| Previous Close | 4.84 |
| Day's Range | 4.86 - 5.12 |
| 52-Week Range | 1.60 - 13.19 |
| Beta | 1.16 |
| Ex-Dividend Date | n/a |
About CATX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CATX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CATX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsPerspective Therapeutics Inc. is scheduled to release its earnings on
Nov 11, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
5 days ago
+25.91%
Perspective Therapeutics shares are trading higher...
Unlock content with
Pro Subscription
4 months ago
+29.29%
Perspective Therapeutics shares are trading higher. RBC Capital maintained Its Outperform on the stock and raised its price target to $16.
